Showing results (751-760 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 20, 2019
Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathwayYufan Zheng, Hairong Chen, Yang Zhao, et al.
Investigational New Drugs|March 20, 2019
Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependentGhenwa Nasreddine, Mirvat El-Sibai, Ralph J Abi-Habib
Investigational New Drugs|March 20, 2019
The exosome secretion inhibitor neticonazole suppresses intestinal dysbacteriosis-induced tumorigenesis of colorectal cancerLei Gu, Yidong Xu, Wangyan Xu, et al.
Investigational New Drugs|February 27, 2019
Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinomaG Beinse, A Hulin, Benoit Rousseau
Investigational New Drugs|April 1, 2019
Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cellsAdam Hermawan, Ratna Asmah Susidarti, Ratna Dwi Ramadani, et al.
Investigational New Drugs|April 3, 2019
Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using NivolumabHayato Kawachi, Daichi Fujimoto, Takeshi Morimoto, et al.
Investigational New Drugs|April 7, 2019
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinomaC Even, U Lassen, J Merchan, et al.
Investigational New Drugs|July 25, 2019
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancerS Lindsey Davis, Dana B Cardin, Safi Shahda, et al.
Investigational New Drugs|January 20, 2017
Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?Christos Fountzilas, Selena Stuart, Brian Hernandez, et al.
Investigational New Drugs|February 3, 2017
Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experienceShinsuke Sasada, Nobuko Ushirozawa, Noriko Kobayashi, et al.
Pageof 372